DRIO
DarioHealth Corp.
Price Chart
Latest Quote
$6.93
| Previous Close | $7.13 |
| Open | $6.91 |
| Day High | $7.11 |
| Day Low | $6.91 |
| Volume | 9,856 |
Stock Information
| Shares Outstanding | 7.31M |
| Total Debt | $31.82M |
| Cash Equivalents | $20.01M |
| Revenue | $21.19M |
| Net Income | $-41.76M |
| Sector | Healthcare |
| Industry | Health Information Services |
| Market Cap | $50.67M |
| EPS (TTM) | $-8.40 |
| Exchange | NCM |
đ Comprehensive Analysis
Company Data
| Enterprise Value | $62.48M |
| Sales | $21.19M |
| Income | $-41.76M |
| Book/sh | $8.55 |
| Cash/sh | $2.74 |
| Employees | 160 |
Financial Ratios
| Quick Ratio | 2.57 |
| Current Ratio | 3.07 |
| Debt/Eq | 51.00 |
Returns & Margins
| ROA | -19.73% |
| ROE | -59.87% |
| Gross Margin | 61.13% |
| Operating Margin | -130.89% |
| Profit Margin | -192.23% |
Ownership
| Insider Ownership | 21.08% |
| Institutional Ownership | 12.03% |
| Insider & Institutional transactions data not available | |
Valuation Ratios
| Forward P/E | -10.19 |
| P/S | 2.39 |
| P/B | 0.81 |
Analyst Data
| Recommendation | none |
| Target Price | $18.50 |
Technical Indicators
| SMA20 | $7.44 |
| SMA50 | $7.58 |
| SMA200 | $10.43 |
| RSI | 12.04 |
| ATR | 0.3824 |
| Shares Float | 5.23M |
| Short Float | 0.99% |
| Short Ratio | 10.59 |
| Volatility | 1.08 |
| Rel Volume | 1.42 |
Performance History
| Week | -3.75% |
| Month | -15.49% |
| Quarter | -15.90% |
| 6 Months | -42.49% |
| YTD | -34.13% |
| Year | -49.86% |
| 3 Years | -92.00% |
| 5 Years | -98.24% |
| 10 Years | -92.93% |
Sign up for free to view detailed scoring breakdown â premium is free during our trial period!
Recent Price History
| Date | Close | Volume |
|---|---|---|
| 2026-06-18 | $6.93 | 9,900 |
| 2026-06-17 | $7.13 | 2,000 |
| 2026-06-16 | $7.12 | 1,600 |
| 2026-06-15 | $7.15 | 1,600 |
| 2026-06-12 | $7.06 | 5,100 |
| 2026-06-11 | $7.20 | 10,600 |
| 2026-06-10 | $7.21 | 6,900 |
| 2026-06-09 | $7.53 | 7,800 |
| 2026-06-08 | $7.52 | 7,600 |
| 2026-06-05 | $7.50 | 5,100 |
| 2026-06-04 | $7.60 | 11,100 |
| 2026-06-03 | $7.65 | 6,900 |
| 2026-06-02 | $7.65 | 6,200 |
| 2026-06-01 | $7.70 | 12,200 |
| 2026-05-29 | $7.75 | 8,100 |
| 2026-05-28 | $7.52 | 9,000 |
| 2026-05-27 | $7.70 | 7,100 |
| 2026-05-26 | $7.51 | 13,000 |
| 2026-05-22 | $7.86 | 2,800 |
| 2026-05-21 | $7.55 | 4,800 |
| 2026-05-20 | $8.00 | 4,900 |
| 2026-05-19 | $8.20 | 4,700 |
About DarioHealth Corp.
DarioHealth Corp. operates as a digital health company in the United States and internationally. Its digital therapeutics platform and suite of solutions deliver personalized and dynamic interventions driven by data analytics and one-on-one coaching for diabetes, hypertension, weight management, musculoskeletal pain, and behavioral health. The company offers Dario Connect, a solution used to create communities around specific health conditions to increase awareness and education; Dario Mind, a behavioral health offering that decreases the symptoms of stress, anxiety, and depression; Dario Move, focuses on improving posture to alleviate pain with medical device; and Dario Health, a self-care application and virtual coaching platform for diabetes, hypertension, and weight management and GLP-1. It also provides bundled full-suite or partial-suite subscriptions. The company was formerly known as LabStyle Innovations Corp. and changed its name to DarioHealth Corp. in July 2016. DarioHealth Corp. was incorporated in 2011 and is based in New York, New York.
đ° Latest News
DarioHealth (DRIO) Upgraded to Buy: Here's Why
Zacks âĸ 2026-06-17T16:00:03ZDarioHealth Corp (DRIO) Q1 2026 Earnings Call Highlights: Navigating Growth and Strategic ...
GuruFocus.com âĸ 2026-05-13T23:01:19ZDarioHealth Q1 Earnings Call Highlights
MarketBeat âĸ 2026-05-13T15:05:50ZDarioHealth Reports Q1 2026 Results: Full Earnings Call Transcript
Benzinga âĸ 2026-05-13T13:12:43ZDarioHealth Corp. (DRIO) Reports Q1 Loss, Beats Revenue Estimates
Zacks âĸ 2026-05-13T11:25:01ZSi-Bone (SIBN) Reports Q1 Loss, Tops Revenue Estimates
Zacks âĸ 2026-05-12T00:05:05ZDelcath Systems, Inc. (DCTH) Reports Q1 Loss, Misses Revenue Estimates
Zacks âĸ 2026-05-07T15:15:04ZPulse Biosciences, Inc (PLSE) Reports Q1 Loss, Lags Revenue Estimates
Zacks âĸ 2026-05-04T12:05:03ZDarioHealth President Steven Nelson on AI, Chronic Care, and the 2026 Growth Story
Stocktwits âĸ 2026-04-29T15:47:08ZHow The DarioHealth (DRIO) Story Is Shifting With New Targets Research And GLP 1 Focus
Simply Wall St. âĸ 2026-03-24T14:05:45ZIncome Statement (Annual)
| Metric | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
| Revenue | ||||
| Reconciled Cost Of Revenue | $9,694,000 | $13,773,000 | $14,368,000 | $18,001,000 |
| Cost Of Revenue | $9,694,000 | $13,773,000 | $14,368,000 | $18,001,000 |
| Total Revenue | $22,359,000 | $27,040,000 | $20,352,000 | $27,656,000 |
| Operating Revenue | $22,359,000 | $27,040,000 | $20,352,000 | $27,656,000 |
| Expenses | ||||
| Interest Expense | $3,020,000 | $0 | $0 | $1,876,000 |
| Total Expenses | $59,014,000 | $84,784,000 | $76,541,000 | $84,466,000 |
| Other Income Expense | $1,304,000 | $16,430,000 | $497,000 | $656,000 |
| Net Non Operating Interest Income Expense | $-6,258,000 | $-3,285,000 | $-3,671,000 | $-6,035,000 |
| Total Other Finance Cost | $4,181,000 | $4,401,000 | $5,539,000 | $4,665,000 |
| Interest Expense Non Operating | $3,020,000 | $0 | $0 | $1,876,000 |
| Operating Expense | $49,320,000 | $71,011,000 | $62,173,000 | $66,465,000 |
| Selling And Marketing Expense | $20,338,000 | $26,350,000 | $23,785,000 | $30,323,000 |
| General And Administrative Expense | $15,191,000 | $20,482,000 | $18,140,000 | $16,493,000 |
| Income & Earnings | ||||
| Net Income From Continuing Operation Net Minority Interest | $-41,714,000 | $-42,747,000 | $-59,427,000 | $-62,193,000 |
| Net Interest Income | $-6,258,000 | $-3,285,000 | $-3,671,000 | $-6,035,000 |
| Interest Income | $943,000 | $1,116,000 | $1,868,000 | $506,000 |
| Normalized Income | $-42,744,160 | $-58,494,734 | $-59,819,630 | $-62,711,240 |
| Net Income From Continuing And Discontinued Operation | $-41,714,000 | $-42,747,000 | $-59,427,000 | $-62,193,000 |
| Total Operating Income As Reported | $-36,655,000 | $-57,744,000 | $-56,189,000 | $-56,810,000 |
| Net Income Common Stockholders | $-61,735,000 | $-40,982,000 | $-63,511,000 | $-63,836,000 |
| Net Income | $-41,714,000 | $-42,747,000 | $-59,427,000 | $-62,193,000 |
| Net Income Including Noncontrolling Interests | $-41,714,000 | $-42,747,000 | $-59,427,000 | $-62,193,000 |
| Net Income Continuous Operations | $-41,714,000 | $-42,747,000 | $-59,427,000 | $-62,193,000 |
| Pretax Income | $-41,609,000 | $-44,599,000 | $-59,363,000 | $-62,189,000 |
| Special Income Charges | $-102,000 | $-70,000 | $0 | - |
| Interest Income Non Operating | $943,000 | $1,116,000 | $1,868,000 | $506,000 |
| Operating Income | $-36,655,000 | $-57,744,000 | $-56,189,000 | $-56,810,000 |
| Gross Profit | $12,665,000 | $13,267,000 | $5,984,000 | $9,655,000 |
| Per Share | ||||
| Diluted EPS | $-10.12 | $-12.27 | $-38.60 | $-50.80 |
| Basic EPS | $-10.12 | $-12.27 | $-38.60 | $-50.80 |
| Other | ||||
| Tax Effect Of Unusual Items | $273,840 | $682,266 | $104,370 | $137,760 |
| Tax Rate For Calcs | $0 | $0 | $0 | $0 |
| Normalized EBITDA (Bullshit earnings) | $-36,755,000 | $-53,602,000 | $-51,701,000 | $-56,252,000 |
| Total Unusual Items | $1,304,000 | $16,430,000 | $497,000 | $656,000 |
| Total Unusual Items Excluding Goodwill | $1,304,000 | $16,430,000 | $497,000 | $656,000 |
| Reconciled Depreciation | $3,138,000 | $7,427,000 | $4,985,000 | $4,717,000 |
| EBITDA (Bullshit earnings) | $-35,451,000 | $-37,172,000 | $-51,204,000 | $-55,596,000 |
| EBIT | $-38,589,000 | $-44,599,000 | $-56,189,000 | $-60,313,000 |
| Diluted Average Shares | $3,982,956 | $2,451,971 | $1,418,598 | $1,181,751 |
| Basic Average Shares | $3,982,956 | $2,451,971 | $1,418,598 | $1,181,751 |
| Diluted NI Availto Com Stockholders | $-61,735,000 | $-40,982,000 | $-63,511,000 | $-63,836,000 |
| Preferred Stock Dividends | $20,021,000 | $-1,765,000 | $4,084,000 | $1,643,000 |
| Tax Provision | $105,000 | $-1,852,000 | $64,000 | $4,000 |
| Other Special Charges | $102,000 | $70,000 | - | - |
| Gain On Sale Of Security | $1,406,000 | $16,500,000 | $497,000 | $656,000 |
| Research And Development | $13,791,000 | $24,179,000 | $20,248,000 | $19,649,000 |
| Selling General And Administration | $35,529,000 | $46,832,000 | $41,925,000 | $46,816,000 |
| Other Gand A | $15,191,000 | $20,482,000 | $18,140,000 | $16,493,000 |
Balance Sheet (Annual)
| Metric | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
| Assets | ||||
| Net Tangible Assets | $-5,436,000 | $-4,170,000 | $11,100,000 | $28,443,000 |
| Total Assets | $110,075,000 | $118,884,000 | $96,389,000 | $119,191,000 |
| Total Non Current Assets | $75,008,000 | $78,355,000 | $49,059,000 | $53,667,000 |
| Other Non Current Assets | $304,000 | $313,000 | $143,000 | $111,000 |
| Non Current Prepaid Assets | $80,000 | $79,000 | $6,000 | $6,000 |
| Goodwill And Other Intangible Assets | $73,358,000 | $76,189,000 | $47,044,000 | $51,556,000 |
| Other Intangible Assets | $15,931,000 | $18,762,000 | $5,404,000 | $9,916,000 |
| Current Assets | $35,067,000 | $40,529,000 | $47,330,000 | $65,524,000 |
| Restricted Cash | $229,000 | $175,000 | $292,000 | $165,000 |
| Prepaid Assets | $1,576,000 | $1,788,000 | $1,536,000 | $908,000 |
| Inventory | $4,316,000 | $4,753,000 | $5,062,000 | $7,956,000 |
| Receivables | $2,929,000 | $5,352,000 | $3,643,000 | $7,138,000 |
| Other Receivables | $785,000 | $548,000 | $488,000 | $722,000 |
| Accounts Receivable | $2,144,000 | $4,804,000 | $3,155,000 | $6,416,000 |
| Allowance For Doubtful Accounts Receivable | $-158,000 | $-169,000 | - | - |
| Gross Accounts Receivable | $2,302,000 | $4,973,000 | - | - |
| Cash Cash Equivalents And Short Term Investments | $26,017,000 | $28,461,000 | $36,797,000 | $49,357,000 |
| Cash And Cash Equivalents | $21,803,000 | $27,764,000 | $36,797,000 | $49,357,000 |
| Loans Receivable | - | - | - | $0 |
| Debt | ||||
| Net Debt | $8,944,000 | $1,159,000 | - | - |
| Total Debt | $31,748,000 | $30,192,000 | $29,541,000 | $28,048,000 |
| Long Term Debt And Capital Lease Obligation | $31,318,000 | $24,237,000 | $25,476,000 | $18,932,000 |
| Long Term Debt | $30,747,000 | $23,472,000 | $24,591,000 | $18,105,000 |
| Current Debt And Capital Lease Obligation | $430,000 | $5,955,000 | $4,065,000 | $9,116,000 |
| Current Debt | - | $5,451,000 | $3,954,000 | $8,823,000 |
| Other Current Borrowings | - | $5,451,000 | $3,954,000 | $8,823,000 |
| Liabilities | ||||
| Total Liabilities Net Minority Interest | $42,153,000 | $46,865,000 | $38,245,000 | $39,192,000 |
| Total Non Current Liabilities Net Minority Interest | $32,830,000 | $30,230,000 | $25,752,000 | $19,842,000 |
| Other Non Current Liabilities | $46,000 | $25,000 | $36,000 | - |
| Derivative Product Liabilities | $1,466,000 | $5,968,000 | $240,000 | $910,000 |
| Current Liabilities | $9,323,000 | $16,635,000 | $12,493,000 | $19,350,000 |
| Current Deferred Liabilities | $714,000 | $1,583,000 | $997,000 | $1,320,000 |
| Payables And Accrued Expenses | $5,330,000 | $4,985,000 | $3,358,000 | $4,507,000 |
| Payables | $2,928,000 | $3,045,000 | $1,131,000 | $2,322,000 |
| Accounts Payable | $2,928,000 | $3,045,000 | $1,131,000 | $2,322,000 |
| Equity | ||||
| Common Stock Equity | $67,922,000 | $72,019,000 | $58,144,000 | $79,999,000 |
| Total Equity Gross Minority Interest | $67,922,000 | $72,019,000 | $58,144,000 | $79,999,000 |
| Stockholders Equity | $67,922,000 | $72,019,000 | $58,144,000 | $79,999,000 |
| Retained Earnings | $-452,078,000 | $-390,343,000 | $-349,361,000 | $-285,850,000 |
| Other | ||||
| Preferred Shares Number | $53,440 | $49,585 | $18,959 | $3,567 |
| Ordinary Shares Number | $6,905,948 | $1,919,421 | $1,359,592 | $1,286,223 |
| Share Issued | $6,905,948 | $1,919,421 | $1,359,592 | $1,286,223 |
| Tangible Book Value | $-5,436,000 | $-4,170,000 | $11,100,000 | $28,443,000 |
| Invested Capital | $98,669,000 | $100,942,000 | $86,689,000 | $106,927,000 |
| Working Capital | $25,744,000 | $23,894,000 | $34,837,000 | $46,174,000 |
| Capital Lease Obligations | $1,001,000 | $1,269,000 | $996,000 | $1,120,000 |
| Total Capitalization | $98,669,000 | $95,491,000 | $82,735,000 | $98,104,000 |
| Additional Paid In Capital | $519,996,000 | $462,358,000 | $407,502,000 | $365,846,000 |
| Capital Stock | $4,000 | $4,000 | $3,000 | $3,000 |
| Common Stock | $4,000 | $4,000 | $3,000 | $3,000 |
| Preferred Stock | $0 | $0 | $0 | $0 |
| Long Term Capital Lease Obligation | $571,000 | $765,000 | $885,000 | $827,000 |
| Current Deferred Revenue | $714,000 | $1,583,000 | $997,000 | $1,320,000 |
| Current Capital Lease Obligation | $430,000 | $504,000 | $111,000 | $293,000 |
| Pensionand Other Post Retirement Benefit Plans Current | $2,849,000 | $4,112,000 | $4,073,000 | $4,407,000 |
| Current Accrued Expenses | $2,402,000 | $1,940,000 | $2,227,000 | $2,185,000 |
| Goodwill | $57,427,000 | $57,427,000 | $41,640,000 | $41,640,000 |
| Net PPE | $1,266,000 | $1,774,000 | $1,866,000 | $1,994,000 |
| Accumulated Depreciation | $-1,007,000 | $-1,911,000 | $-1,489,000 | $-1,439,000 |
| Gross PPE | $2,273,000 | $3,685,000 | $3,355,000 | $3,433,000 |
| Leases | $350,000 | $336,000 | $326,000 | $141,000 |
| Other Properties | $853,000 | $2,095,000 | $1,955,000 | $2,194,000 |
| Machinery Furniture Equipment | $1,070,000 | $1,254,000 | $1,074,000 | $1,098,000 |
| Properties | $0 | $0 | $0 | $0 |
| Finished Goods | $3,565,000 | $4,190,000 | $4,047,000 | $6,610,000 |
| Raw Materials | $751,000 | $563,000 | $1,015,000 | $1,346,000 |
| Other Short Term Investments | $4,214,000 | $697,000 | $0 | - |
| Treasury Shares Number | - | - | $0 | - |
Cash Flow Statement (Annual)
| Metric | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
| Free Cash Flow | ||||
| Free Cash Flow | $-26,083,000 | $-38,700,000 | $-30,963,000 | $-48,418,000 |
| Operating Activities | ||||
| Operating Cash Flow | $-25,941,000 | $-38,562,000 | $-30,379,000 | $-47,845,000 |
| Cash Flow From Continuing Operating Activities | $-25,941,000 | $-38,562,000 | $-30,379,000 | $-47,845,000 |
| Operating Gains Losses | $-1,681,000 | $-16,504,000 | $-670,000 | - |
| Investing Activities | ||||
| Capital Expenditure | $-142,000 | $-138,000 | $-584,000 | $-573,000 |
| Investing Cash Flow | $-4,342,000 | $-8,934,000 | $-547,000 | $-573,000 |
| Cash Flow From Continuing Investing Activities | $-4,342,000 | $-8,934,000 | $-547,000 | $-573,000 |
| Net Other Investing Changes | - | - | - | - |
| Financing Activities | ||||
| Issuance Of Capital Stock | $24,128,000 | $38,531,000 | $16,482,000 | $38,288,000 |
| Financing Cash Flow | $24,313,000 | $38,531,000 | $18,253,000 | $61,940,000 |
| Cash Flow From Continuing Financing Activities | $24,313,000 | $38,531,000 | $18,253,000 | $61,940,000 |
| Net Preferred Stock Issuance | $6,754,000 | $38,531,000 | $14,868,000 | $0 |
| Preferred Stock Issuance | $6,754,000 | $38,531,000 | $14,868,000 | $0 |
| Net Common Stock Issuance | $17,374,000 | $0 | $1,614,000 | $38,154,000 |
| Common Stock Issuance | $17,374,000 | $0 | $1,614,000 | $38,288,000 |
| Repurchase Of Capital Stock | - | - | $0 | $-134,000 |
| Other | ||||
| Repayment Of Debt | $-31,515,000 | $0 | $-27,833,000 | $0 |
| Issuance Of Debt | $31,700,000 | $0 | $29,604,000 | $23,786,000 |
| Interest Paid Supplemental Data | $3,493,000 | $3,927,000 | $4,031,000 | $1,876,000 |
| End Cash Position | $21,803,000 | $27,764,000 | $36,797,000 | $49,470,000 |
| Beginning Cash Position | $27,764,000 | $36,797,000 | $49,470,000 | $35,948,000 |
| Effect Of Exchange Rate Changes | $9,000 | $-68,000 | $0 | - |
| Changes In Cash | $-5,970,000 | $-8,965,000 | $-12,673,000 | $13,522,000 |
| Net Issuance Payments Of Debt | $185,000 | $0 | $1,771,000 | $23,786,000 |
| Net Long Term Debt Issuance | $185,000 | $0 | $1,771,000 | $23,786,000 |
| Long Term Debt Payments | $-31,515,000 | $0 | $-27,833,000 | $0 |
| Long Term Debt Issuance | $31,700,000 | $0 | $29,604,000 | $23,786,000 |
| Net Investment Purchase And Sale | $-4,200,000 | $0 | $37,000 | $0 |
| Purchase Of Investment | $-4,200,000 | $0 | $-4,996,000 | $0 |
| Net Business Purchase And Sale | $0 | $-8,796,000 | $0 | $0 |
| Purchase Of Business | $0 | $-8,796,000 | $0 | $0 |
| Net PPE Purchase And Sale | $-142,000 | $-138,000 | $-584,000 | $-442,000 |
| Purchase Of PPE | $-142,000 | $-138,000 | $-584,000 | $-442,000 |
| Change In Working Capital | $1,390,000 | $-2,470,000 | $4,074,000 | $-10,899,000 |
| Change In Other Working Capital | $-869,000 | $-156,000 | $-323,000 | $125,000 |
| Change In Other Current Liabilities | $-341,000 | $-1,150,000 | $-124,000 | $833,000 |
| Change In Other Current Assets | $421,000 | $907,000 | $239,000 | $-919,000 |
| Change In Payables And Accrued Expense | $-902,000 | $-3,979,000 | $-1,447,000 | $-4,101,000 |
| Change In Payable | $-902,000 | $-3,979,000 | $-1,447,000 | $-4,101,000 |
| Change In Account Payable | $-122,000 | $-496,000 | $-1,191,000 | $-2,787,000 |
| Change In Inventory | $437,000 | $308,000 | $2,894,000 | $-1,728,000 |
| Change In Receivables | $2,644,000 | $1,600,000 | $2,835,000 | $-5,109,000 |
| Changes In Account Receivables | $2,660,000 | $1,680,000 | $3,261,000 | $-5,106,000 |
| Other Non Cash Items | $3,561,000 | $-64,000 | $958,000 | $3,555,000 |
| Stock Based Compensation | $9,365,000 | $15,796,000 | $19,701,000 | $16,975,000 |
| Depreciation Amortization Depletion | $3,138,000 | $7,427,000 | $4,985,000 | $4,717,000 |
| Depreciation And Amortization | $3,138,000 | $7,427,000 | $4,985,000 | $4,717,000 |
| Amortization Cash Flow | $2,831,000 | $6,100,000 | $4,512,000 | $4,361,000 |
| Amortization Of Intangibles | $2,831,000 | $6,100,000 | $4,512,000 | $4,361,000 |
| Depreciation | $307,000 | $1,327,000 | $473,000 | $356,000 |
| Gain Loss On Investment Securities | $-1,681,000 | $-16,504,000 | $-670,000 | - |
| Net Income From Continuing Operations | $-41,714,000 | $-42,747,000 | $-59,427,000 | $-62,193,000 |
| Sale Of Investment | - | $0 | $5,033,000 | $0 |
| Common Stock Payments | - | - | $0 | $-134,000 |
| Net Intangibles Purchase And Sale | - | - | $0 | $-131,000 |
| Purchase Of Intangibles | - | - | $0 | $-131,000 |
| Proceeds From Stock Option Exercised | - | - | - | $0 |